首页 > 最新文献

Skin Pharmacology and Physiology最新文献

英文 中文
MiR-211 regulates cutaneous wound healing through inhibiting inflammatory reactions and oxidative stress by binding SOX11.
IF 2.8 4区 医学 Q2 DERMATOLOGY Pub Date : 2025-01-27 DOI: 10.1159/000542697
Yun Chen, Xinyi Zhang, Fangfang Wu, Lixia Wang, Hongju Zuo, Hanbing Tian, Huan Chen

Introduction: Loss of skin integrity due to a wound or disease can lead to severe disability or even life threat. The highly expressed microRNAs in the skin are of great significance for skin development. The investigation purposed to explore the effect and mechanism of miR-211 on inflammation, oxidative stress and migration in keratinocytes.

Methods: The HaCaT keratinocytes were treated with hydrogen peroxide (H2O2) to establish a wound-healing model. The expression of miR-211 was examined by quantitative real-time PCR (qRT-PCR). The cell function was reflected in proliferative ability, migration, apoptosis, and inflammation, which were evaluated by Cell Counting Kit-8 (CCK-8) assay, Transwell test, flow cytometry technique, and enzyme-linked immunosorbent assay (ELISA). The target of miR-211 was verified by luciferase luminescence measurements.

Results: H2O2 inhibited HaCaT cell proliferation, migration, and promoted cell apoptosis, accompanied with the downregulation of miR-211. H2O2 led to inflammatory response and oxidative damage to HaCaT. MiR-211 promoted proliferation and migration, but improved cell apoptosis of HaCaT. The role of H2O2 on inflammatory response and oxidative stress was alleviated by miR-211. SRY-box transcription factor 11 (SOX11) was a targeted mediator of miR-211. SOX11 reversed the influence of miR-211 on cell proliferation, migration, apoptosis, inflammatory response and oxidative stress.

Conclusion: MiR-211 regulated proliferation, migration, apoptosis, inflammation and oxidative stress of keratinocytes by mediating SOX11, thus participating in cutaneous wound healing.

{"title":"MiR-211 regulates cutaneous wound healing through inhibiting inflammatory reactions and oxidative stress by binding SOX11.","authors":"Yun Chen, Xinyi Zhang, Fangfang Wu, Lixia Wang, Hongju Zuo, Hanbing Tian, Huan Chen","doi":"10.1159/000542697","DOIUrl":"https://doi.org/10.1159/000542697","url":null,"abstract":"<p><strong>Introduction: </strong>Loss of skin integrity due to a wound or disease can lead to severe disability or even life threat. The highly expressed microRNAs in the skin are of great significance for skin development. The investigation purposed to explore the effect and mechanism of miR-211 on inflammation, oxidative stress and migration in keratinocytes.</p><p><strong>Methods: </strong>The HaCaT keratinocytes were treated with hydrogen peroxide (H2O2) to establish a wound-healing model. The expression of miR-211 was examined by quantitative real-time PCR (qRT-PCR). The cell function was reflected in proliferative ability, migration, apoptosis, and inflammation, which were evaluated by Cell Counting Kit-8 (CCK-8) assay, Transwell test, flow cytometry technique, and enzyme-linked immunosorbent assay (ELISA). The target of miR-211 was verified by luciferase luminescence measurements.</p><p><strong>Results: </strong>H2O2 inhibited HaCaT cell proliferation, migration, and promoted cell apoptosis, accompanied with the downregulation of miR-211. H2O2 led to inflammatory response and oxidative damage to HaCaT. MiR-211 promoted proliferation and migration, but improved cell apoptosis of HaCaT. The role of H2O2 on inflammatory response and oxidative stress was alleviated by miR-211. SRY-box transcription factor 11 (SOX11) was a targeted mediator of miR-211. SOX11 reversed the influence of miR-211 on cell proliferation, migration, apoptosis, inflammatory response and oxidative stress.</p><p><strong>Conclusion: </strong>MiR-211 regulated proliferation, migration, apoptosis, inflammation and oxidative stress of keratinocytes by mediating SOX11, thus participating in cutaneous wound healing.</p>","PeriodicalId":21748,"journal":{"name":"Skin Pharmacology and Physiology","volume":" ","pages":"1-18"},"PeriodicalIF":2.8,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143053274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How to Choose an Emollient? Pharmaceutical and sensory attributes for product selection. 如何选择润肤剂?产品选择的药学和感官属性。
IF 2.8 4区 医学 Q2 DERMATOLOGY Pub Date : 2025-01-20 DOI: 10.1159/000543653
Petra Huber, Daphne Reinau, Zoé Brodard, Christoph R Meier, Christian Surber

Introduction: Emollients are part of daily body care and have become indispensable therapeutic adjuvants for the treatment of dry skin conditions. Adherence to topical treatments, notably for dry skin conditions, has been reported to be low. The underlying reasons may include insufficient medical and nursing support for product selection, specific product attributes, aspects of product application, and product feel on the skin. Attempts have also been made to portray lipid content, galenic product format, or rheological attributes (pharmaceutical attributes) as adherence-promoting or adherence-preventing properties. In the treatment of dry dermatoses with emollients, there is little information describing and relating to these various features. We explored whether the sensory attributes of selected emollients were associated with common product attributes such as lipid content, viscosity, or galenic product format, and discuss the extent to which this information is useful for product selection.

Methods: Nine trained panellists evaluated ten selected emollients based on a set of 18 predefined sensory attributes according to a standard guide for sensory descriptive analysis. Viscosity was determined using a rotational rheometer.

Results: The emollients had product-specific sensory attributes. Lipid content, viscosity, and galenic product format are not generally indicative of sensory product attributes.

Conclusions: Contrary to popular belief, lipid content and viscosity are not generally indicative of sensory product attributes. This is mainly due to the different physicochemical properties of the lipid phase ingredients, which are product-specific and diverse. As most emollients contain significant amounts of volatile ingredients that evaporate during and after application, their galenic format changes dramatically. Therefore, this is not a viable selection criterion. Because refined information on sensory product attributes, as compiled for this study, is rarely available in everyday life, eliciting individual and subjective patient preferences through dialogue remains crucial. Ideally, patient preferences can be elicited from the sample packs.

润肤剂是日常身体护理的一部分,已成为治疗皮肤干燥状况不可或缺的治疗辅助剂。据报道,局部治疗的依从性很低,特别是对皮肤干燥的情况。潜在的原因可能包括对产品选择的医疗和护理支持不足、产品的特定属性、产品应用的各个方面以及产品对皮肤的感觉。也有人试图将脂质含量、galenic产品格式或流变特性(药物特性)描述为促进或防止粘附的特性。在用润肤剂治疗干性皮肤病时,很少有描述和与这些不同特征相关的信息。我们探讨了所选润肤剂的感官属性是否与常见的产品属性(如脂质含量、粘度或galenic产品格式)相关,并讨论了这些信息在多大程度上对产品选择有用。方法:9名训练有素的小组成员根据感官描述性分析的标准指南,根据一组18个预定义的感官属性评估10种选定的润肤剂。粘度是用旋转流变仪测定的。结果:润肤剂具有产品特有的感官属性。脂质含量,粘度,和加仑产品格式一般不指示感官产品属性。结论:与普遍的看法相反,脂质含量和粘度通常不能指示感官产品的属性。这主要是由于脂相成分的理化性质不同,具有产品特异性和多样性。由于大多数润肤剂含有大量的挥发性成分,在使用期间和之后蒸发,它们的加仑格式发生了巨大的变化。因此,这不是一个可行的选择标准。由于为本研究编制的关于感官产品属性的精细信息在日常生活中很少可用,因此通过对话引发个体和主观的患者偏好仍然至关重要。理想情况下,患者的偏好可以从样品包中得出。
{"title":"How to Choose an Emollient? Pharmaceutical and sensory attributes for product selection.","authors":"Petra Huber, Daphne Reinau, Zoé Brodard, Christoph R Meier, Christian Surber","doi":"10.1159/000543653","DOIUrl":"https://doi.org/10.1159/000543653","url":null,"abstract":"<p><strong>Introduction: </strong>Emollients are part of daily body care and have become indispensable therapeutic adjuvants for the treatment of dry skin conditions. Adherence to topical treatments, notably for dry skin conditions, has been reported to be low. The underlying reasons may include insufficient medical and nursing support for product selection, specific product attributes, aspects of product application, and product feel on the skin. Attempts have also been made to portray lipid content, galenic product format, or rheological attributes (pharmaceutical attributes) as adherence-promoting or adherence-preventing properties. In the treatment of dry dermatoses with emollients, there is little information describing and relating to these various features. We explored whether the sensory attributes of selected emollients were associated with common product attributes such as lipid content, viscosity, or galenic product format, and discuss the extent to which this information is useful for product selection.</p><p><strong>Methods: </strong>Nine trained panellists evaluated ten selected emollients based on a set of 18 predefined sensory attributes according to a standard guide for sensory descriptive analysis. Viscosity was determined using a rotational rheometer.</p><p><strong>Results: </strong>The emollients had product-specific sensory attributes. Lipid content, viscosity, and galenic product format are not generally indicative of sensory product attributes.</p><p><strong>Conclusions: </strong>Contrary to popular belief, lipid content and viscosity are not generally indicative of sensory product attributes. This is mainly due to the different physicochemical properties of the lipid phase ingredients, which are product-specific and diverse. As most emollients contain significant amounts of volatile ingredients that evaporate during and after application, their galenic format changes dramatically. Therefore, this is not a viable selection criterion. Because refined information on sensory product attributes, as compiled for this study, is rarely available in everyday life, eliciting individual and subjective patient preferences through dialogue remains crucial. Ideally, patient preferences can be elicited from the sample packs.</p>","PeriodicalId":21748,"journal":{"name":"Skin Pharmacology and Physiology","volume":" ","pages":"1-15"},"PeriodicalIF":2.8,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143011101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
REFLECTANCE CONFOCAL MICROSCOPY OF DERMAL PAPILLAE IN HEALTHY SKIN: A HISTOPATHOLOGY CONTROLLED STUDY. 健康皮肤真皮乳头的反射共聚焦显微镜:一项组织病理学对照研究。
IF 2.8 4区 医学 Q2 DERMATOLOGY Pub Date : 2025-01-17 DOI: 10.1159/000543491
Francesco Lacarrubba, Anna Elisa Verzì, Cosimo Misciali, Davide Domenicali, Giuseppe Micali

Introduction: Previous studies have investigated the density of dermal papillae (DP) in normal skin using reflectance confocal microscopy (RCM), a non-invasive imaging technique that allows a real time, high-resolution imaging of the skin, although no histological confirmation was provided. The aim of the present study was to compare the RCM evaluation of DP density in healthy skin with horizontal histopathological sections (HHS), a technique that provides a horizontal view of the skin.

Methods: Ten adult patients were selected, and a healthy skin area was marked for RCM examination and a subsequent 5-mm punch biopsy that was processed for HHS. Two different blinded operators performed DP counting on RCM and HHS images, respectively.

Results: A total of 10 skin samples were obtained from the lower back. The mean DP density resulting from RCM was 84.27±3.24/mm2, while that from HHS was 84.08±2.74/mm2. Student T-test showed no significant differences in DP count between the two techniques (P=0.89).

Discussion: The strength of this study is represented by the histological evaluation which has never been previously performed, whose results align with the RCM findings and validate previous data from our group, with negligible differences. We believe that the exact identification of the DP number in normal skin may have practical implications, as several inflammatory skin conditions are characterized by DP changes such as psoriasis, lichen planus, and discoid lupus.

先前的研究使用反射共聚焦显微镜(RCM)研究了正常皮肤中真皮乳头(DP)的密度,RCM是一种非侵入性成像技术,尽管没有提供组织学证实,但可以实现皮肤的实时、高分辨率成像。本研究的目的是比较RCM对健康皮肤DP密度的评估与水平组织病理学切片(HHS),一种提供皮肤水平视图的技术。方法:选择10名成年患者,标记健康皮肤区域进行RCM检查,随后进行5毫米穿孔活检,以进行HHS处理。两种不同的盲法操作分别对RCM和HHS图像进行DP计数。结果:共获得下背部皮肤样本10份。RCM的平均DP密度为84.27±3.24/mm2, HHS的平均DP密度为84.08±2.74/mm2。学生t检验显示两种方法的DP计数差异无统计学意义(P=0.89)。讨论:本研究的强度由以前从未进行过的组织学评估来表示,其结果与RCM结果一致,并验证了我们组以前的数据,差异可以忽略不计。我们认为,在正常皮肤中准确识别DP值可能具有实际意义,因为一些炎症性皮肤病的特征是DP改变,如牛皮癣、扁平苔藓和盘状狼疮。
{"title":"REFLECTANCE CONFOCAL MICROSCOPY OF DERMAL PAPILLAE IN HEALTHY SKIN: A HISTOPATHOLOGY CONTROLLED STUDY.","authors":"Francesco Lacarrubba, Anna Elisa Verzì, Cosimo Misciali, Davide Domenicali, Giuseppe Micali","doi":"10.1159/000543491","DOIUrl":"https://doi.org/10.1159/000543491","url":null,"abstract":"<p><strong>Introduction: </strong>Previous studies have investigated the density of dermal papillae (DP) in normal skin using reflectance confocal microscopy (RCM), a non-invasive imaging technique that allows a real time, high-resolution imaging of the skin, although no histological confirmation was provided. The aim of the present study was to compare the RCM evaluation of DP density in healthy skin with horizontal histopathological sections (HHS), a technique that provides a horizontal view of the skin.</p><p><strong>Methods: </strong>Ten adult patients were selected, and a healthy skin area was marked for RCM examination and a subsequent 5-mm punch biopsy that was processed for HHS. Two different blinded operators performed DP counting on RCM and HHS images, respectively.</p><p><strong>Results: </strong>A total of 10 skin samples were obtained from the lower back. The mean DP density resulting from RCM was 84.27±3.24/mm2, while that from HHS was 84.08±2.74/mm2. Student T-test showed no significant differences in DP count between the two techniques (P=0.89).</p><p><strong>Discussion: </strong>The strength of this study is represented by the histological evaluation which has never been previously performed, whose results align with the RCM findings and validate previous data from our group, with negligible differences. We believe that the exact identification of the DP number in normal skin may have practical implications, as several inflammatory skin conditions are characterized by DP changes such as psoriasis, lichen planus, and discoid lupus.</p>","PeriodicalId":21748,"journal":{"name":"Skin Pharmacology and Physiology","volume":" ","pages":"1-6"},"PeriodicalIF":2.8,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143011109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In vitro Antibacterial and Antifungal Activity of a Skin Ointment and Its Active Pharmaceutical Ingredients Larch Turpentine, Turpentine Oil, and Eucalyptus Oil. 皮肤软膏及其活性药物成分落叶松节油、松节油和桉树油的体外抗菌和抗真菌活性。
IF 2.8 4区 医学 Q2 DERMATOLOGY Pub Date : 2025-01-10 DOI: 10.1159/000543158
Elisa Pianta, Nils Günnewich, Christian Zimmermann, Orlando Petrini, Juan Diaz-Miyar, Cristina Fragoso-Corti

Introduction: Turpentine derivatives and eucalyptus oil are herbal substances traditionally used to treat various skin infections. Limited non-clinical data suggest they exert an immunological activity, but only scant information exists on their antibiotic effects. This in vitro study has been carried out to investigate the antibacterial and antifungal activity of a marketed skin ointment; its active pharmaceutical ingredients larch turpentine, eucalyptus oil, and turpentine oil; and their mixture, against bacteria and yeasts commonly present on the skin and causing skin infections.

Methods: The antibiotic activity was tested using the drop dilution assay on the Gram-positive bacteria Staphylococcus aureus (wild type), a methicillin-resistant S. aureus strain, S. epidermidis, S. haemolyticus, Streptococcus pyogenes, the Gram-negative Pseudomonas aeruginosa, and the yeasts Candida albicans and C. tropicalis.

Results: The ointment exerts a strong inhibitory effect on all Gram-positive bacteria at a concentration of 5 g/100 mL in the Müller-Hinton medium. It also has inhibiting effect on both Candida species but does not inhibit P. aeruginosa growth. As for the single active pharmaceutical ingredients, larch turpentine was the most active substance. The mixture of the three ingredients, in the concentrations used in the ointment, had a higher antibiotic effect than any of the individual ingredients studied, suggesting at least an additive activity.

Conclusions: Our study has shown that the herbal ingredients and their combination exert antimicrobial activities, especially against Gram-positive bacteria, that justify their use in the treatment of skin infections.

简介:松节油衍生物和桉树油是传统上用于治疗各种皮肤感染的草药物质。有限的非临床数据表明它们发挥免疫活性,但关于它们的抗生素作用的信息很少。这项体外研究是为了调查一种已上市的皮肤软膏的抗菌和抗真菌活性,它的活性药物成分是落叶松松节油、桉树油和松节油,以及它们的混合物,对皮肤上常见的细菌和酵母菌的抗菌和抗真菌活性,这些细菌和酵母菌会导致皮肤感染。方法:采用滴稀释法对革兰氏阳性菌金黄色葡萄球菌(野生型)、耐甲氧西林金黄色葡萄球菌、表皮葡萄球菌、溶血葡萄球菌、化脓性链球菌、革兰氏阴性菌铜绿假单胞菌、酵母菌白色念珠菌和热带葡萄球菌进行抗生素活性检测。结果:该软膏在 ller- hinton培养基中浓度为5 g/100 mL时,对所有革兰氏阳性菌均有较强的抑制作用。对两种念珠菌均有抑制作用,但对铜绿假单胞菌无抑制作用。在单一活性药物成分中,落叶松节油的活性最高。这三种成分的混合物,在软膏中使用的浓度,具有比任何单独研究的成分更高的抗生素效果,这表明至少有一种添加剂活性。结论:我们的研究表明,草药成分及其组合具有抗菌活性,特别是对革兰氏阳性细菌,证明其用于治疗皮肤感染是合理的。
{"title":"In vitro Antibacterial and Antifungal Activity of a Skin Ointment and Its Active Pharmaceutical Ingredients Larch Turpentine, Turpentine Oil, and Eucalyptus Oil.","authors":"Elisa Pianta, Nils Günnewich, Christian Zimmermann, Orlando Petrini, Juan Diaz-Miyar, Cristina Fragoso-Corti","doi":"10.1159/000543158","DOIUrl":"10.1159/000543158","url":null,"abstract":"<p><strong>Introduction: </strong>Turpentine derivatives and eucalyptus oil are herbal substances traditionally used to treat various skin infections. Limited non-clinical data suggest they exert an immunological activity, but only scant information exists on their antibiotic effects. This in vitro study has been carried out to investigate the antibacterial and antifungal activity of a marketed skin ointment; its active pharmaceutical ingredients larch turpentine, eucalyptus oil, and turpentine oil; and their mixture, against bacteria and yeasts commonly present on the skin and causing skin infections.</p><p><strong>Methods: </strong>The antibiotic activity was tested using the drop dilution assay on the Gram-positive bacteria Staphylococcus aureus (wild type), a methicillin-resistant S. aureus strain, S. epidermidis, S. haemolyticus, Streptococcus pyogenes, the Gram-negative Pseudomonas aeruginosa, and the yeasts Candida albicans and C. tropicalis.</p><p><strong>Results: </strong>The ointment exerts a strong inhibitory effect on all Gram-positive bacteria at a concentration of 5 g/100 mL in the Müller-Hinton medium. It also has inhibiting effect on both Candida species but does not inhibit P. aeruginosa growth. As for the single active pharmaceutical ingredients, larch turpentine was the most active substance. The mixture of the three ingredients, in the concentrations used in the ointment, had a higher antibiotic effect than any of the individual ingredients studied, suggesting at least an additive activity.</p><p><strong>Conclusions: </strong>Our study has shown that the herbal ingredients and their combination exert antimicrobial activities, especially against Gram-positive bacteria, that justify their use in the treatment of skin infections.</p>","PeriodicalId":21748,"journal":{"name":"Skin Pharmacology and Physiology","volume":" ","pages":"1-8"},"PeriodicalIF":2.8,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142954671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Reactive Oxygen Species in the Pathogenesis of Alopecia Areata: A Systematic Review and Meta-Analysis. 活性氧在斑秃发病机制中的作用:系统回顾和荟萃分析。
IF 2.8 4区 医学 Q2 DERMATOLOGY Pub Date : 2025-01-02 DOI: 10.1159/000543373
Jonah Perlmutter, Polycronis P Akouris, Sierra Fremont, Brian Yang, Evan Toth, Michael Eze, Marni Wiseman

Background: Alopecia areata (AA) is a T-cell-mediated autoimmune disease that significantly impacts patient quality of life. The breakdown of hair follicle immune privilege underlies AA pathogenesis. However, the precise mechanism of this breakdown remains unclear. This study investigates the potential role of reactive oxygen species in AA pathogenesis.

Summary: A systematic review and meta-analysis were conducted on observational studies and randomized controlled trials from 2000 to 2024. Studies included AA patients and measured oxidative stress index (OSI), malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), or paraoxonase-1 (PON1). Extracted data were analyzed using the Cochrane risk-of-bias tool and random-effects models. The review included 21 studies with 743 AA patients. OSI was elevated in AA patients (effect size = 1.58, 95% CI: 0.31-2.68, p = 0.00068). MDA levels were also elevated (effect size = 1.60, 95% CI: 0.43-2.6, p = 0.00023), while SOD (effect size = -0.97, 95% CI: -1.65 to -0.30, p = 0.00066) and GSH-Px (effect size = -1.41, 95% CI: -2.28 to -0.53, p = 0.00068) activities were reduced. PON1 levels showed no significant difference (effect size = -3.56, 95% CI: -8.63 to 1.51, p = 0.051).

Key messages: The elevated OSI and MDA, and decreased antioxidant activity in AA patients suggest a substantial role for reactive oxygen species and oxidative stress in AA pathogenesis, highlighting oxidative stress as a potential target for therapeutic intervention. These results underscore the importance of oxidative stress in AA and support further research into antioxidant-based therapies.

背景:斑秃(AA)是一种t细胞介导的自身免疫性疾病,严重影响患者的生活质量。毛囊免疫特权的破坏是AA发病的基础。然而,这种崩溃的确切机制仍不清楚。本研究探讨活性氧在AA发病机制中的潜在作用。摘要:对2000年至2024年的观察性研究和随机对照试验进行了系统回顾和荟萃分析。研究纳入AA患者,并测量氧化应激指数(OSI)、丙二醛(MDA)、超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)或对氧磷酶-1 (PON1)。提取的数据使用Cochrane偏倚风险工具和随机效应模型进行分析。该综述包括21项研究,743例AA患者。AA患者的OSI升高(效应值= 1.58,95% CI [0.31-2.68], p = 0.00068)。MDA水平也升高(效应值= 1.60,95% CI [0.43-2.6], p = 0.00023),而SOD(效应值= -0.97,95% CI [-1.65 ~ -0.30], p = 0.00066)和GSH-Px(效应值= -1.41,95% CI [-2.28 ~ -0.53], p = 0.00068)活性降低。PON1水平无显著差异(效应值= -3.56,95% CI [-8.63 ~ 1.51], p = 0.051)。关键信息:AA患者的OSI、MDA升高和抗氧化活性降低提示活性氧和氧化应激在AA发病机制中起重要作用,强调氧化应激是治疗干预的潜在靶点。这些结果强调了氧化应激在AA中的重要性,并支持进一步研究以抗氧化剂为基础的治疗方法。
{"title":"The Role of Reactive Oxygen Species in the Pathogenesis of Alopecia Areata: A Systematic Review and Meta-Analysis.","authors":"Jonah Perlmutter, Polycronis P Akouris, Sierra Fremont, Brian Yang, Evan Toth, Michael Eze, Marni Wiseman","doi":"10.1159/000543373","DOIUrl":"10.1159/000543373","url":null,"abstract":"<p><strong>Background: </strong>Alopecia areata (AA) is a T-cell-mediated autoimmune disease that significantly impacts patient quality of life. The breakdown of hair follicle immune privilege underlies AA pathogenesis. However, the precise mechanism of this breakdown remains unclear. This study investigates the potential role of reactive oxygen species in AA pathogenesis.</p><p><strong>Summary: </strong>A systematic review and meta-analysis were conducted on observational studies and randomized controlled trials from 2000 to 2024. Studies included AA patients and measured oxidative stress index (OSI), malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), or paraoxonase-1 (PON1). Extracted data were analyzed using the Cochrane risk-of-bias tool and random-effects models. The review included 21 studies with 743 AA patients. OSI was elevated in AA patients (effect size = 1.58, 95% CI: 0.31-2.68, p = 0.00068). MDA levels were also elevated (effect size = 1.60, 95% CI: 0.43-2.6, p = 0.00023), while SOD (effect size = -0.97, 95% CI: -1.65 to -0.30, p = 0.00066) and GSH-Px (effect size = -1.41, 95% CI: -2.28 to -0.53, p = 0.00068) activities were reduced. PON1 levels showed no significant difference (effect size = -3.56, 95% CI: -8.63 to 1.51, p = 0.051).</p><p><strong>Key messages: </strong>The elevated OSI and MDA, and decreased antioxidant activity in AA patients suggest a substantial role for reactive oxygen species and oxidative stress in AA pathogenesis, highlighting oxidative stress as a potential target for therapeutic intervention. These results underscore the importance of oxidative stress in AA and support further research into antioxidant-based therapies.</p>","PeriodicalId":21748,"journal":{"name":"Skin Pharmacology and Physiology","volume":" ","pages":"1-9"},"PeriodicalIF":2.8,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142922819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Rigorously Simple Quantitative Model for Free Radical Behavior in Aerobic Biological Systems. 有氧生物系统中自由基行为的严格简单定量模型。
IF 2.8 4区 医学 Q2 DERMATOLOGY Pub Date : 2024-11-16 DOI: 10.1159/000542600
Leonhard Zastrow, Jürgen Lademann, Martina C Meinke, Silke B Lohan

Background: Human life is based on oxygen respiration and an enzymatic, free radical-dependent water chemistry, whose billions of parallel reactions take place at pH ∼7.4 and a temperature of 37°C, in accordance with the laws of chemistry. The cellular metabolic processes occur over time periods covered by the half-lives of reactive oxygen species (ROS) for °OH to over 10 s for lipid oxygen species (LOS), indicating that mixtures of free radicals form the basic components for these processes.

Summary: The main source of radicals is the mitochondrial conversion of 1-5% oxygen into "primary" ROS and "secondary" LOS. Every endogenous and exogenous radical generation, triggered by "natural background radiation," "natural environment," or "solar radiation" leads to qualitatively similar mixtures of "primary" ROS and "secondary" LOS or RNS (reactive nitrogen species). A Multilevel Antioxidant Regulation, Repair and Protection System (MARRPS) keeps these radical mixtures in a steady state. Depending on the total number of free radicals, different areas of radical action are defined. The Free Radical Ground State (FRGS) with "homeostasis" and "adaptive homeostasis," the Free Radical Threshold Value (FRTV), and Free Radical Pathological Conditions (FRPC). The quantitative ratio ROS > LOS comprehensively characterizes the "'homeostasis" and "adaptive homeostasis" area of the FRGS. The total number of free radicals cannot be measured directly in the "homeostasis" area. "Adaptive homeostasis" is achieved when excess radicals are stable produced beyond "homeostasis" of the FRGS. The quantity that remains controllable in this range is a maximum of ∼3.58 × 1012 radicals/mg, the value of the body constant FRTV. The sensitized MARRPS provides "semi-stable homeostatic" states characterized by dual stability with ROS > LOS and a stable total ROS/LOS and RNS count beyond the basal FRGS "homeostasis." If the total number of all radicals exceeds the FRTV, where LOS > ROS, this initiates uncontrolled radical chain reactions. The partial failure of the MARRPS in the FRPC area leads to pathological processes which are the starting point for a hundred different diseases.

Key messages: The universal body constant FRTV is the basis for all regular life processes. The design principle described by this simple model applies universally to all aerobic life.

背景 人类生命的基础是氧呼吸和依赖于酶的自由基水化学,其数十亿个平行反应在 pH ∼ 7.4 和 37°C 的温度下按照化学规律进行。细胞新陈代谢过程发生的时间跨度从 ROS(活性氧)的半衰期(°OH)到 LOS(脂氧)的 10 秒以上,这表明自由基混合物构成了这些过程的基本成分。总结和重要信息 自由基的主要来源是线粒体将 1-5%的氧气转化为 "一级 "ROS 和 "二级 "LOS。由 "天然本底辐射"、"自然环境 "或 "太阳辐射 "引发的每一种内源性和外源性自由基的产生,都会导致 "初级 "ROS 和 "次级 "LOS 或 RNS(活性氮物种)质量相似的混合物。多级抗氧化调节、修复和保护系统(MARRPS)可使这些自由基混合物保持稳定状态。根据自由基总量的不同,自由基的作用区域也不同。自由基原态(FRGS)包括 "稳态 "和 "适应稳态"、自由基阈值(FRTV)和自由基病理状态(FRPC)。ROS > LOS 的定量比值全面描述了 FRGS 的 "稳态 "和 "适应性稳态 "区域。在 "稳态 "区域无法直接测量自由基的总数。当过量自由基的稳定产生超出 FRGS 的 "稳态 "范围时,就实现了 "适应性稳态"。在此范围内,可控制的自由基数量最大为 3.58 10¹²个/毫克,即人体常数 FRTV 的值。敏化的 MARRPS 可提供 "半稳定平衡 "状态,其特点是 ROS > LOS 双重稳定,ROS/LOS 和 RNS 总量稳定,超出了 FRGS 基础 "平衡 "状态。如果所有自由基的总数超过 FRTV,即 LOS > ROS,就会引发失控的自由基连锁反应。在 FRPC 区域,MARRPS 的部分失效会导致病理过程,而这正是百种不同疾病的起点。这个简单模型所描述的设计原理普遍适用于所有有氧生命。
{"title":"A Rigorously Simple Quantitative Model for Free Radical Behavior in Aerobic Biological Systems.","authors":"Leonhard Zastrow, Jürgen Lademann, Martina C Meinke, Silke B Lohan","doi":"10.1159/000542600","DOIUrl":"10.1159/000542600","url":null,"abstract":"<p><strong>Background: </strong>Human life is based on oxygen respiration and an enzymatic, free radical-dependent water chemistry, whose billions of parallel reactions take place at pH ∼7.4 and a temperature of 37°C, in accordance with the laws of chemistry. The cellular metabolic processes occur over time periods covered by the half-lives of reactive oxygen species (ROS) for °OH to over 10 s for lipid oxygen species (LOS), indicating that mixtures of free radicals form the basic components for these processes.</p><p><strong>Summary: </strong>The main source of radicals is the mitochondrial conversion of 1-5% oxygen into \"primary\" ROS and \"secondary\" LOS. Every endogenous and exogenous radical generation, triggered by \"natural background radiation,\" \"natural environment,\" or \"solar radiation\" leads to qualitatively similar mixtures of \"primary\" ROS and \"secondary\" LOS or RNS (reactive nitrogen species). A Multilevel Antioxidant Regulation, Repair and Protection System (MARRPS) keeps these radical mixtures in a steady state. Depending on the total number of free radicals, different areas of radical action are defined. The Free Radical Ground State (FRGS) with \"homeostasis\" and \"adaptive homeostasis,\" the Free Radical Threshold Value (FRTV), and Free Radical Pathological Conditions (FRPC). The quantitative ratio ROS > LOS comprehensively characterizes the \"'homeostasis\" and \"adaptive homeostasis\" area of the FRGS. The total number of free radicals cannot be measured directly in the \"homeostasis\" area. \"Adaptive homeostasis\" is achieved when excess radicals are stable produced beyond \"homeostasis\" of the FRGS. The quantity that remains controllable in this range is a maximum of ∼3.58 × 1012 radicals/mg, the value of the body constant FRTV. The sensitized MARRPS provides \"semi-stable homeostatic\" states characterized by dual stability with ROS > LOS and a stable total ROS/LOS and RNS count beyond the basal FRGS \"homeostasis.\" If the total number of all radicals exceeds the FRTV, where LOS > ROS, this initiates uncontrolled radical chain reactions. The partial failure of the MARRPS in the FRPC area leads to pathological processes which are the starting point for a hundred different diseases.</p><p><strong>Key messages: </strong>The universal body constant FRTV is the basis for all regular life processes. The design principle described by this simple model applies universally to all aerobic life.</p>","PeriodicalId":21748,"journal":{"name":"Skin Pharmacology and Physiology","volume":" ","pages":"1-14"},"PeriodicalIF":2.8,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142648727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Brief Review of Vehicles for Topical Therapies. 局部疗法载体简评
IF 2.7 4区 医学 Q2 DERMATOLOGY Pub Date : 2024-09-12 DOI: 10.1159/000541418
Kripa Ahuja,Miranda An,Peter Lio
Background Topical therapy has been a fundamental part of dermatology, evolving from early ointments to advanced transdermal treatments. These formulations allow for effective management of skin conditions by maximizing local drug delivery and minimizing systemic effects. Modern topical therapies continue to benefit from innovations that improve both efficacy and patient outcomes. Summary Topical formulations consist of a vehicle and active ingredients, with the vehicle enhancing drug absorption and patient experience. Historically categorized by physical properties, vehicles are vital in drug delivery. Recent innovations, such as nanoemulsions and derma-membrane structures, offer improved skin penetration and therapeutic results, representing significant advancements in topical treatment options. Key Messages Topical therapies provide targeted, effective treatment in dermatology with minimal systemic side effects. Vehicle choice is essential to therapy success, and innovations such as nanoemulsions are improving drug delivery and patient care. Ongoing research into novel delivery systems continues to enhance the future of dermatological treatments.
背景 外用疗法一直是皮肤病学的基本组成部分,从早期的软膏发展到先进的透皮疗法。这些制剂通过最大限度地增加局部给药量和减少全身影响来有效治疗皮肤病。现代外用疗法不断从创新中获益,从而提高了疗效,改善了患者的预后。摘要 外用制剂由载体和活性成分组成,载体可促进药物吸收,改善患者体验。载体历来按物理特性分类,在给药过程中至关重要。纳米乳剂和皮肤膜结构等最新创新技术可提高皮肤渗透性和治疗效果,是外用治疗方法的重大进步。关键信息 外用疗法为皮肤病提供了有针对性的有效治疗,并将全身副作用降至最低。载体的选择对治疗的成功至关重要,而纳米乳剂等创新技术正在改善药物输送和患者护理。对新型给药系统的持续研究将继续促进皮肤病治疗的未来发展。
{"title":"A Brief Review of Vehicles for Topical Therapies.","authors":"Kripa Ahuja,Miranda An,Peter Lio","doi":"10.1159/000541418","DOIUrl":"https://doi.org/10.1159/000541418","url":null,"abstract":"Background Topical therapy has been a fundamental part of dermatology, evolving from early ointments to advanced transdermal treatments. These formulations allow for effective management of skin conditions by maximizing local drug delivery and minimizing systemic effects. Modern topical therapies continue to benefit from innovations that improve both efficacy and patient outcomes. Summary Topical formulations consist of a vehicle and active ingredients, with the vehicle enhancing drug absorption and patient experience. Historically categorized by physical properties, vehicles are vital in drug delivery. Recent innovations, such as nanoemulsions and derma-membrane structures, offer improved skin penetration and therapeutic results, representing significant advancements in topical treatment options. Key Messages Topical therapies provide targeted, effective treatment in dermatology with minimal systemic side effects. Vehicle choice is essential to therapy success, and innovations such as nanoemulsions are improving drug delivery and patient care. Ongoing research into novel delivery systems continues to enhance the future of dermatological treatments.","PeriodicalId":21748,"journal":{"name":"Skin Pharmacology and Physiology","volume":"20 1","pages":"1-9"},"PeriodicalIF":2.7,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142269257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diesel Particulate Matter Permeation into Normal Human Skin and Intervention Using a Topical Ceramide Formulation. 柴油微粒物质向正常人体皮肤的渗透以及使用局部神经酰胺配方进行干预。
IF 2.8 4区 医学 Q2 DERMATOLOGY Pub Date : 2024-01-01 Epub Date: 2024-05-22 DOI: 10.1159/000539291
Kyong-Oh Shin, Kenya Ishida, Hisashi Mihara, Yerim Choi, Jae-Ho Park, Soo-Hyun Park, Jin-Taek Hwang, Joan S Wakefield, Yasuko Obata, Yoshikazu Uchida, Kyungho Park

Introduction: Diesel particulate matter (DPM) emitted from diesel engines is a major source of air pollutants. DPM is composed of elemental carbon, which adsorbs organic compounds including toxic polycyclic aromatic hydrocarbons (PAHs). The skin, as well as airways, is directly exposed to DPM, and association of atopic dermatitis, psoriasis flares, and premature skin aging with air pollutant levels has been documented. In skin, the permeation of DPM and DPM-adsorbed compounds is primarily blocked by the epidermal permeability barrier deployed in the stratum corneum. Depending upon the integrity of this barrier, certain amounts of DPM and DPM-adsorbed compounds can permeate into the skin. However, this permeation into human skin has not been completely elucidated.

Methods: We assessed the permeation of PAHs (adsorbed to DPM) into skin using ex vivo normal (barrier-competent) organ-cultured human skin after application of DPM. Two major PAHs, 2-methylnaphthalene and triphenylene, and a carcinogenic PAH, benzo(a)pyrene, all found in DPM, were measured in the epidermis and dermis using liquid chromatography electrospray ionization tandem mass spectrometry. In addition, we investigated whether a topical formulation can attenuate the permeation of DPM into skin.

Results: 2-Methylnaphthalene, triphenylene, and benzo(a)pyrene were recovered from the epidermis. Although these PAHs were also detected in the dermis after DPM application, these PAH levels were significantly lower than those found in the epidermis. We also demonstrated that a topical formulation that has the ability to form more uniform membrane structures can significantly suppress the permeation of PAHs adsorbed to DPM into the skin.

Conclusion: Toxic compounds adsorbed by DPM can permeate even barrier-competent skin. Hence, barrier-compromised skin, such as in atopic dermatitis, psoriasis, and xerosis, is even more vulnerable to air pollutants. A properly formulated topical mixture that forms certain membrane structures on the skin surface can effectively prevent permeation of exogenous substances, including DPM, into skin.

导言:柴油发动机排放的柴油微粒物质(DPM)是空气污染物的主要来源。DPM 由元素碳组成,能吸附有机化合物,包括有毒的多环芳烃(PAH)。皮肤和呼吸道都会直接接触到 DPM,特应性皮炎、牛皮癣复发和皮肤过早老化与空气污染物水平之间的联系已被证实。在皮肤中,DPM 和 DPM 吸附化合物的渗透主要受到角质层中表皮渗透屏障的阻挡。视该屏障的完整性而定,一定量的二苯基甲烷和二苯基甲烷吸附化合物可渗透到皮肤中。然而,这种向人体皮肤的渗透尚未完全阐明:方法:我们使用体内外正常(具有屏障功能)器官培养的人体皮肤,评估了多环芳烃(吸附在 DPM 上)在涂抹 DPM 后向皮肤的渗透情况。使用液相色谱电喷雾串联质谱法测量了表皮和真皮中的两种主要多环芳烃(2-甲基萘和三苯乙烯)以及一种致癌多环芳烃(PAH)--苯并(a)芘,所有这些物质都存在于 DPM 中。此外,我们还研究了外用制剂是否可以减少二苯基甲烷对皮肤的渗透。结果:从表皮中回收了 2-甲基萘、三苯乙烯和苯并(a)芘。虽然在施用二苯基甲烷后也在真皮中检测到了这些多环芳烃,但这些多环芳烃的含量明显低于表皮中的含量。我们还证明,能够形成更均匀膜结构的外用制剂可以大大抑制吸附在 DPM 上的 PAH 向皮肤的渗透:结论:DPM 吸附的有毒化合物甚至可以渗透到屏障功能良好的皮肤中。因此,屏障功能受损的皮肤(如特应性皮炎、牛皮癣和干癣)更容易受到空气污染物的伤害。适当配制的局部混合物可在皮肤表面形成某些膜结构,从而有效防止外源性物质(包括二苯基甲烷)渗入皮肤。
{"title":"Diesel Particulate Matter Permeation into Normal Human Skin and Intervention Using a Topical Ceramide Formulation.","authors":"Kyong-Oh Shin, Kenya Ishida, Hisashi Mihara, Yerim Choi, Jae-Ho Park, Soo-Hyun Park, Jin-Taek Hwang, Joan S Wakefield, Yasuko Obata, Yoshikazu Uchida, Kyungho Park","doi":"10.1159/000539291","DOIUrl":"10.1159/000539291","url":null,"abstract":"<p><strong>Introduction: </strong>Diesel particulate matter (DPM) emitted from diesel engines is a major source of air pollutants. DPM is composed of elemental carbon, which adsorbs organic compounds including toxic polycyclic aromatic hydrocarbons (PAHs). The skin, as well as airways, is directly exposed to DPM, and association of atopic dermatitis, psoriasis flares, and premature skin aging with air pollutant levels has been documented. In skin, the permeation of DPM and DPM-adsorbed compounds is primarily blocked by the epidermal permeability barrier deployed in the stratum corneum. Depending upon the integrity of this barrier, certain amounts of DPM and DPM-adsorbed compounds can permeate into the skin. However, this permeation into human skin has not been completely elucidated.</p><p><strong>Methods: </strong>We assessed the permeation of PAHs (adsorbed to DPM) into skin using ex vivo normal (barrier-competent) organ-cultured human skin after application of DPM. Two major PAHs, 2-methylnaphthalene and triphenylene, and a carcinogenic PAH, benzo(a)pyrene, all found in DPM, were measured in the epidermis and dermis using liquid chromatography electrospray ionization tandem mass spectrometry. In addition, we investigated whether a topical formulation can attenuate the permeation of DPM into skin.</p><p><strong>Results: </strong>2-Methylnaphthalene, triphenylene, and benzo(a)pyrene were recovered from the epidermis. Although these PAHs were also detected in the dermis after DPM application, these PAH levels were significantly lower than those found in the epidermis. We also demonstrated that a topical formulation that has the ability to form more uniform membrane structures can significantly suppress the permeation of PAHs adsorbed to DPM into the skin.</p><p><strong>Conclusion: </strong>Toxic compounds adsorbed by DPM can permeate even barrier-competent skin. Hence, barrier-compromised skin, such as in atopic dermatitis, psoriasis, and xerosis, is even more vulnerable to air pollutants. A properly formulated topical mixture that forms certain membrane structures on the skin surface can effectively prevent permeation of exogenous substances, including DPM, into skin.</p>","PeriodicalId":21748,"journal":{"name":"Skin Pharmacology and Physiology","volume":" ","pages":"32-39"},"PeriodicalIF":2.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141071624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of a pH-Regulating Emollient Cream in Mild Atopic Dermatitis Patients with Moderate Localized Lesions. 调节 pH 值的润肤霜对局部中度病变的轻度特应性皮炎患者的影响
IF 2.8 4区 医学 Q2 DERMATOLOGY Pub Date : 2024-01-01 Epub Date: 2024-08-28 DOI: 10.1159/000541022
Sue Phay Ng, Stephan Bielfeldt, Sabrina Laing, Simon Danby, Michael J John Cork

Introduction: Increased skin pH values in patients with atopic dermatitis (AD) contribute to poor antimicrobial and permeability barrier functions of the skin. In practice, the majority of topical preparations available for dry skin conditions do not provide sufficient pH and buffering capacity for maintaining optimum skin surface conditions. To address this issue, we tested a novel zinc lactobionate preparation to determine whether the regular application would lower skin surface pH, and in doing so improve the condition of lesional skin.

Methods: The assessment for local severity of AD was done with the Scoring Atopic Dermatitis Index (SCORAD) and skin dryness was assessed by capacitance measurement.

Results: The results showed that the test product lowered skin pH and improved AD skin lesions from moderate to mild during 2 weeks of application. In the treated area a lowered pH of about 0.85 units was found. Together with the lowering of pH, the local SCORAD significantly improved from 8.3 on average down to 4.0, while in the untreated area, only a slight improvement (from 8.2 to 6.4) was found.

Conclusion: Synergistic effects of the test product's pH lowering and emollient properties might explain the observed improvements in clinical signs of AD and further research against a comparator would allow the specific contribution of pH modulation to these improvements to be unambiguously isolated.

导言:特应性皮炎(AD)患者皮肤 pH 值升高会导致皮肤抗菌和渗透屏障功能低下。实际上,大多数治疗干性皮肤病的外用制剂并不能提供足够的 pH 值和缓冲能力来维持皮肤表面的最佳状态。为了解决这个问题,我们测试了一种新型乳糖酸锌制剂,以确定定期使用是否会降低皮肤表面的 pH 值,从而改善病变皮肤的状况:方法:用 SCORAD 评估 AD 的局部严重程度,用电容测量法评估皮肤干燥程度:结果表明,试验产品能降低皮肤的 pH 值,并在使用 2 周后将特应性皮炎的皮损从中度改善为轻度。在接受治疗的部位,pH 值降低了约 0.85 个单位。在降低 pH 值的同时,局部的 SCORAD 值也得到了显著改善,从平均值 8.3 降至 4.0,而未治疗部位的 SCORAD 值仅有轻微改善(从 8.2 降至 6.4):试验产品的 pH 值降低和润肤特性的协同作用可能是所观察到的 AD 临床症状得到改善的原因,而针对对比试验的进一步研究将能明确区分 pH 值调节对这些改善的具体作用。
{"title":"Effects of a pH-Regulating Emollient Cream in Mild Atopic Dermatitis Patients with Moderate Localized Lesions.","authors":"Sue Phay Ng, Stephan Bielfeldt, Sabrina Laing, Simon Danby, Michael J John Cork","doi":"10.1159/000541022","DOIUrl":"10.1159/000541022","url":null,"abstract":"<p><strong>Introduction: </strong>Increased skin pH values in patients with atopic dermatitis (AD) contribute to poor antimicrobial and permeability barrier functions of the skin. In practice, the majority of topical preparations available for dry skin conditions do not provide sufficient pH and buffering capacity for maintaining optimum skin surface conditions. To address this issue, we tested a novel zinc lactobionate preparation to determine whether the regular application would lower skin surface pH, and in doing so improve the condition of lesional skin.</p><p><strong>Methods: </strong>The assessment for local severity of AD was done with the Scoring Atopic Dermatitis Index (SCORAD) and skin dryness was assessed by capacitance measurement.</p><p><strong>Results: </strong>The results showed that the test product lowered skin pH and improved AD skin lesions from moderate to mild during 2 weeks of application. In the treated area a lowered pH of about 0.85 units was found. Together with the lowering of pH, the local SCORAD significantly improved from 8.3 on average down to 4.0, while in the untreated area, only a slight improvement (from 8.2 to 6.4) was found.</p><p><strong>Conclusion: </strong>Synergistic effects of the test product's pH lowering and emollient properties might explain the observed improvements in clinical signs of AD and further research against a comparator would allow the specific contribution of pH modulation to these improvements to be unambiguously isolated.</p>","PeriodicalId":21748,"journal":{"name":"Skin Pharmacology and Physiology","volume":" ","pages":"49-58"},"PeriodicalIF":2.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11488831/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142093714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Bioequivalence and Pharmacokinetic Profiles for Topical Desonide Cream Using Chinese Skins. 用中国人的皮肤评价外用地索奈德乳膏的生物等效性和药代动力学特征。
IF 2.8 4区 医学 Q2 DERMATOLOGY Pub Date : 2024-01-01 Epub Date: 2024-08-19 DOI: 10.1159/000540782
Yuanyuan Sun, Nan Yang, Jie Huang, An Yao, Ling Ye, Shuang Yang, Min Xiao, Xuqing Zhang, Jinsong Ding, Yun Kuang, Yali Zhou, Guoping Yang

Introduction: Skin-blanching assay has been established as a surrogate method for assessing bioequivalence of topical corticosteroids. This study aimed to apply the skin-blanching assay to evaluate the bioequivalence of a test desonide cream (T) compared with the reference Desonide® (R) using Chinese skins. Additionally, the pharmacokinetics and safety profiles were also assessed.

Methods: By detecting the degree of skin blanching under different dose durations in a pilot dose-duration-response study, the area under the observed effect-time curve (AUEC) and half of the maximum effect (ED50) was calculated. Based on this, the skin color of different time points after a dose duration of ED50, D1 (0.5 × ED50), and D2 (2 × ED50) were detected as a pharmacodynamic indicator to compare between test and reference creams. Single-center, single-dose, randomized, open-label, two-cycle crossover pharmacokinetic studies were designed to make sure the exposure of tested formulationswas not higher than that of the reference formulations. Subjects experiencing adverse events (AEs) were monitored and utilized for safety analysis.

Results: These studies involved 12 subjects for the dose-duration-response study, 100 subjects for the bioequivalence study, and 12 subjects for the pharmacokinetic study. The results showed that the population ED50 was 0.88 ± 0.45 h; the mean ratio of area under effective curve from 0 to 24 h (AUEC0-24h) of test and reference preparations was 0.95, with a 90% confidence interval as 88.09-101.72%, indicating the bioequivalence of the test formulation and Desonide®. The maximum plasma concentration (Cmax) and area under the concentration time curve from time 0 to the last time point (AUC0-t) of T and R were 20.8 ± 11.5 pg/mL versus 19.7 ± 10.1 pg/mL, respectively, and 451.04 ± 363.65 pgh/mL versus 541.47 ± 581.41 pgh/mL, respectively. The systemic exposure of a single dose of the test cream was not higher than that of the reference preparation. All of the volunteers experienced grade 1 AEs, suggesting that single administration of the test desonide cream is well tolerated in the Chinese healthy population.

Conclusions: This study demonstrated the applicability of skin-blanching assay in Chinese skins and established the bioequivalence of test and reference desonide creams.

简介皮肤灼伤试验已被确定为评估外用皮质类固醇生物等效性的替代方法。本研究旨在使用中国人的皮肤,采用皮肤灼热试验来评估试验用的地索奈德乳膏(T)与参考用的地索奈德®(R)的生物等效性。此外,还对药代动力学和安全性进行了评估:方法:在一项剂量-持续时间-反应试验研究中,通过检测不同剂量持续时间下的皮肤褪色程度,计算了观察效应时间曲线下面积(AUEC)和最大效应的一半(ED50)。在此基础上,检测了 ED50、D1(0.5×ED50)和 D2(2×ED50)剂量持续时间后不同时间点的皮肤颜色,作为药效学指标来比较试验药膏和参考药膏。为了确保受试制剂的暴露量不高于参比制剂,我们设计了一项单中心、单剂量、随机、开放标签、两周期交叉药代动力学研究。对出现不良事件(AEs)的受试者进行了监测,并用于安全性分析:这些研究中,12 名受试者参与了剂量-持续时间-反应研究,100 名受试者参与了生物等效性研究,12 名受试者参与了药代动力学研究。结果表明,受试者的 ED50 为 0.88±0.45 h,受试制剂与参比制剂的有效曲线下面积(AUEC0-24h)的平均比值为 0.95,90% 置信区间为 88.09%-101.72%,表明受试制剂与得生泰®具有生物等效性。T和R的最大浓度(Cmax)和暴露量(AUC0-t)分别为20.8 ± 11.5 pg/mL和19.7 ± 10.1 pg/mL,以及451.04 ± 363.65 pg∙h/mL 和541.47 ± 581.41 pg∙h/mL 。单剂量试验乳膏的全身暴露量并不比参比制剂高。所有志愿者都出现了一级不良反应(AEs),这表明中国健康人群对单次给药的地索奈德乳膏具有良好的耐受性:本研究证明了皮肤灼热试验在中国人皮肤中的适用性,并确定了供试制剂和参比制剂的生物等效性。
{"title":"Evaluation of Bioequivalence and Pharmacokinetic Profiles for Topical Desonide Cream Using Chinese Skins.","authors":"Yuanyuan Sun, Nan Yang, Jie Huang, An Yao, Ling Ye, Shuang Yang, Min Xiao, Xuqing Zhang, Jinsong Ding, Yun Kuang, Yali Zhou, Guoping Yang","doi":"10.1159/000540782","DOIUrl":"10.1159/000540782","url":null,"abstract":"<p><strong>Introduction: </strong>Skin-blanching assay has been established as a surrogate method for assessing bioequivalence of topical corticosteroids. This study aimed to apply the skin-blanching assay to evaluate the bioequivalence of a test desonide cream (T) compared with the reference Desonide® (R) using Chinese skins. Additionally, the pharmacokinetics and safety profiles were also assessed.</p><p><strong>Methods: </strong>By detecting the degree of skin blanching under different dose durations in a pilot dose-duration-response study, the area under the observed effect-time curve (AUEC) and half of the maximum effect (ED50) was calculated. Based on this, the skin color of different time points after a dose duration of ED50, D1 (0.5 × ED50), and D2 (2 × ED50) were detected as a pharmacodynamic indicator to compare between test and reference creams. Single-center, single-dose, randomized, open-label, two-cycle crossover pharmacokinetic studies were designed to make sure the exposure of tested formulationswas not higher than that of the reference formulations. Subjects experiencing adverse events (AEs) were monitored and utilized for safety analysis.</p><p><strong>Results: </strong>These studies involved 12 subjects for the dose-duration-response study, 100 subjects for the bioequivalence study, and 12 subjects for the pharmacokinetic study. The results showed that the population ED50 was 0.88 ± 0.45 h; the mean ratio of area under effective curve from 0 to 24 h (AUEC0-24h) of test and reference preparations was 0.95, with a 90% confidence interval as 88.09-101.72%, indicating the bioequivalence of the test formulation and Desonide®. The maximum plasma concentration (Cmax) and area under the concentration time curve from time 0 to the last time point (AUC0-t) of T and R were 20.8 ± 11.5 pg/mL versus 19.7 ± 10.1 pg/mL, respectively, and 451.04 ± 363.65 pgh/mL versus 541.47 ± 581.41 pgh/mL, respectively. The systemic exposure of a single dose of the test cream was not higher than that of the reference preparation. All of the volunteers experienced grade 1 AEs, suggesting that single administration of the test desonide cream is well tolerated in the Chinese healthy population.</p><p><strong>Conclusions: </strong>This study demonstrated the applicability of skin-blanching assay in Chinese skins and established the bioequivalence of test and reference desonide creams.</p>","PeriodicalId":21748,"journal":{"name":"Skin Pharmacology and Physiology","volume":" ","pages":"70-79"},"PeriodicalIF":2.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142005175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Skin Pharmacology and Physiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1